All News
How are RA patients doing using telemedicine/virtual care?
Rheumatologists switched their practices overnight from primarily in person to nearly all virtual care as COVID-19 pandemic geared up in March 2020 and then to a blend of in person and virtual care. How are RA patients doing?
Read Article
New ACR RA Guidelines and Practice Changing Abstracts: RA Panel
Dr. Jonathan Kay leads an international panel discussion on the new ACR RA guidelines and several practice-changing abstracts presented at the 2020 ACR meeting. Panelists include Dr. Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.
Read Article
ACR has released 2 free powerpoint slide decks featuring select RA and SLE abstracts from #ACR20 (a 3rd late-breaking slide deck is yet to come!). Download here>> https://t.co/CiNH0xfs7J
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recs for RA: MTX is conditionally recommended with NORMAL LFTs and no advanced fibrosis. Role of HCQ for NALFD has been suggested at ACR, but not enough for mod-high disease activity @RheumNow. https://t.co/XswkhT1f66 https://t.co/bdngrnY9hc
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : Switching or adding a DMARD in pts w/ mod-high dz RA activity ; hx of previous serious infection w/in the past 12 mos as opposed to starting/increasing GCs is conditionally recommended per draft recs of new ACR RA treatment guidelines.
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @KDAO2011 : Very strong push by #ACR20 to recc MTX in most RA patient scenarios including RA ILD, RA nodules, NAFLD in new RA guidance document @rheumnow
Dr. John Cush RheumNow ( View Tweet)
Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway ( @RichardPAConway) discusses ACR abstract #1445 presented #ACR20
https://t.co/WjcBPay86P https://t.co/JnUVss0FDK
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @DrMiniDey : Patient-physician discordance seen in ~30% RA patients starting #DMARDs
- ↑Patient-reported pain; functional impairment assoc. w/ discordance
- Patient-centric treatment discussions needed to reduce discordance
Abs#1978
https://t.co/uTJehn5Qs5 https://t.co/289d3VsE22
Dr. John Cush RheumNow ( View Tweet)
RA Risk Factors and Early RA: Dr. Jeffrey Sparks ( @jeffsparks) and Dr. Janet Pope ( @Janetbirdope) #ACR20
https://t.co/vN7Dt60R4W https://t.co/K5vAhEQfks
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Kay leads an internat'l panel of rheums to elicit their opinions on key abstracts at #ACR20.
Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks.
https://t.co/Jg6QiswnnJ https://t.co/UAqiN3F734
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : Wonder if you can predict development of clinical RA in those at risk either w/ a
- +RF or +CCP
- Relevant sxs w/ or w/o abs
- 1st deg relatives do RA pts?
#ACR20 https://t.co/xVZHxL35UY
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RADoctor: Adjuvant #herpeszoster vaccine (Shingrix) not effective for 25% of JAKi-treated RA pts (n=40) for antibody response (T cell response usually worse, not reported). Is better than nothing good enough? Maybe we need to hold JAKi briefly?
Dr. John Cush RheumNow ( View Tweet)
New ACR RA Guidelines and Practice Changing Abstracts #ACR20
https://t.co/3lGSUDks8F
Links:
Dr. John Cush RheumNow ( View Tweet)
Check this out!
Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20
https://t.co/dAgYOFMMJC https://t.co/QV02h171yP
Links:
Dr. John Cush RheumNow ( View Tweet)
"Erosions on X-ray: can we delegate this to the computers?" by Dr. David Liew ( @drdavidliew) #ACR20
https://t.co/YvKjAWebT9 https://t.co/RS4P29UVym
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and ILD: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Jeffrey Sparks ( @jeffsparks) about abstracts #0392, #0491, #1198 and #0489 presented at #ACR20.
https://t.co/e6HI1SqqSf https://t.co/naXAo8nc1g
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACRO20Tweets
"RT @RHEUMarampa : Large cohort of older RA pts newly rx w/HCQ or MTX:
👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ.
@RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/4gK7hwdhIr" https://t.co/JsGBFrp7Hl
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA https://t.co/JH07pMjvRe https://t.co/H9LHwiw4xL
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @DrMiniDey : Late breaking: in older #rheumatoidarthritis patients, those taking MTX have 2x risk of #VTE compared to those on HCQ. Important to consider #thromboembolic risk factors when starting new RA treatment.
Abs#2000 #ACR20
https://t.co/lMYlXgaHyE https://t.co/0Fdone9yb3
Links:
Dr. John Cush RheumNow ( View Tweet)
Watch this three minute video on Subclinical Synovitis with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/rGqgseyWBv https://t.co/6snzAjbuaU
Links:
Dr. John Cush RheumNow ( View Tweet)
